Loading…
Ken GriffinAdded
Citadel Advisors · Q2 2026
$72.1M
265.61K shares · 0.0% of portfolio
Natera, Inc.
Natera, Inc. (NTRA) is listed on NASDAQ and classified in Diagnostics & Research, part of the Healthcare sector. It is headquartered in Austin, United States and has 6,135 employees. The company is worth $57.86B. Revenue was $2.31B in fiscal 2025, up 35.9% from the year before. It reported a net loss of $208.16M. The share price is 8.2% below its 52-week high of $437.41. 10 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Stanley Druckenmiller (Duquesne Family Office), at $864.92M. In that quarter, 5 of them opened or added to the position and 5 reduced it. Over the last 30 days, company insiders sold $29.51M of its stock on the open market and bought none. All of those sales were scheduled in advance under 10b5-1 plans.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▲ +330.2% over 5Y.
today you would have $3,434.06▲ +243.4%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 11 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $229.09 | $158.30 | $62.64 | $40.17 | $93.39 | $99.52 | $33.69 | $13.96 | $8.99 | $11.71 | $10.80 | |
| P/S | 7.0x | 14.1x | 12.6x | 7.0x | 5.5x | 14.3x | 22.0x | 8.7x | 3.4x | 2.3x | 2.8x | 2.9x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CAHCardinal Health Inc | $255.64 | 35.4x | — | 0.81% | — | $59.2B |
| ARGXArgenx SE | $875.76 | 34.0x | 7.4x | 0.00% | 23.64% | $55.07B |
| BDXBecton Dickinson & Co | $200.42 | 46.6x | 2.2x | 2.10% | 6.61% | $54.59B |
| VEEVVeeva Systems Inc | $322.55 |
| P/B | 13.6x | 19.0x | 17.9x | 9.9x | 6.4x | 13.6x | 17.7x | 9.5x | 27.3x | 19.1x | 4.3x | 2.4x |
| EPS | -$1.52 | -$1.53 | -$3.78 | -$5.57 | -$5.21 | -$2.84 | -$1.79 | -$2.22 | -$2.59 | -$1.95 | -$2.68 |
| Profit margin | -46.22% | -9.03% | -11.22% | -40.16% | -66.79% | -75.42% | -58.76% | -41.29% | -49.74% | -65.25% | -46.22% | -36.92% |
| ROE | -56.81% | -12.16% | -15.93% | -56.81% | -77.62% | -72.20% | -47.25% | -44.79% | -398.46% | -541.48% | -69.88% | -31.04% |
Median of the years shown; P/E years above 200x are left out.
| 52.5x |
| 7.0x |
| 0.00% |
| 14.43% |
| $52.22B |
| EWEdwards Lifesciences Corp | $90.09 | 53.6x | 4.9x | 0.00% | 9.18% | $51.93B |
| CORCencora, Inc. | $338.48 | 25.3x | 21.2x | 0.71% | 96.87% | $64.59B |
